WEIGHT loss jabs could raise the risk of sudden blindness, a study warns. Injections like Wegovy, Mounjaro and Ozempic are ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

Weight loss is an ‘achievement’ that never goes out of trend, and that very trend doesn’t seem to stay away from headlines.

Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural ...

Eli Lilly’s trial evaluating Mounjaro in reducing cardiovascular risk met its endpoint, though missed analyst expectations.

At six months, people taking Mounjaro shed 10.1% of their weight, while patients on Ozempic lost 5.9% Eli Lilly’s Mounjaro patients “were significantly more likely to achieve 5%, 10% and 15% ...

TAMPA, FL / ACCESS Newswire / July 29, 2025 / The explosive popularity of GLP-1 weight-loss medications such as Ozempic®, ...

Three months into taking the weight loss drugs, those taking Mounjaro had experienced a nearly 6% change in body weight, compared to a 3.6% change for those taking Ozempic.

RELATED: Ozempic and Mounjaro Patients Report Potentially Fatal New Side Effect. In speaking with The Cut, Jodi LoGerfo, DNP, a nurse practitioner and hair-loss specialist, points to telogen effluvium ...

Ozempic/Wegovy and Mounjaro both lower the hemoglobin A1C (HbA1c) levels—a measure of a person’s average blood sugar levels over a period of about three months—in people with type 2 diabetes.

In the lawsuit filed Aug. 2, attorneys for Jaclyn Bjorklund said she used Ozempic for over a year until starting before taking Mounjaro in July 2023.

Ozempic and Mounjaro were approved by the FDA in 2017 and 2022, respectively, as treatments for Type 2 diabetes. They are not approved for weight loss but can be prescribed off-label by doctors.